Systemic OPA1 overexpression reshapes cardiovascular metabolism and cardiac physiology during high-fat diet feeding
Vascular Pharmacology · 2026-12 · 165 · 107713
DOI: 10.1016/j.vph.2026.107713 ↗Kurz gefasst
Fachartikel in der Zeitschrift Vascular Pharmacology, 2026-12. Verfasst von Lorenzo Da Dalt und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacological and Biomolecular Sciences "Rodolfo Paoletti", Università degli Studi di Milano, Via Balzaretti, 9, 20133 Milan, Italy. Die Arbeit nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fondazione Umberto Veronesi, Ministero dell'Istruzione dell'Università e della Ricerca, European Atherosclerosis Society.
Abstract (Originalsprache)
INTRODUCTION: Optic atrophy 1 (OPA1) is a mitochondrial inner-membrane GTPase that coordinates mitochondrial fusion, cristae organization, and respiratory efficiency. Beyond mitochondrial bioenergetics, OPA1 contributes to cardiovascular homeostasis, including the maintenance of vascular cell function and phenotype. Although increasing OPA1 expression has been proposed to improve mitochondrial performance, the consequences of sustained OPA1-driven oxidative activation in the lipid-exposed cardiovascular system remain incompletely defined. Here, we investigated cardiac structure, tissue metabolism, and cardiomyocyte bioenergetics in mice with systemic OPA1 overexpression maintained on a high-fat diet (HFD). METHODS: OPA1-overexpressing mice were fed high-fat diet for 20 weeks, followed by indirect calorimetry and echocardiographic analysis. Tissues were used for OMICs investigation and metabolic analysis. RESULTS: OPA1-overexpressing mice displayed preserved global left-ventricular systolic function and ventricular volumes but presented reduced anterior and lateral wall thickness. Histological analysis further revealed a decrease in cardiomyocyte cross-sectional area accompanied by increased myocardial collagen deposition. Cardiac triglyceride content was elevated, whereas cholesterol content was unchanged. In neonatal cardiomyocytes, OPA1 overexpression resulted in increased oxygen consumption, with the strongest response observed in cells co-incubated with very-low-density lipoprotein. Under this lipid-rich condition, ATP-linked respiration, maximal respiration, and spare respiratory capacity were increased. DISCUSSION: Collectively, these findings indicate that systemic OPA1 overexpression was associated with myocardial lipid accumulation and early fibrotic remodeling during HFD feeding, despite preserved systolic function. In vitro, OPA1 overexpression increased cardiomyocyte respiratory capacity under lipid-rich conditions. These data identify a context-dependent effect of OPA1 in which enhanced respiratory capacity may become maladaptive when lipid supply exceeds coordinated oxidative and storage capacity.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmacological and Biomolecular Sciences "Rodolfo Paoletti", Università degli Studi di Milano, Via Balzaretti, 9, 20133 Milan, Italy.
- Department of Pharmaceutical Sciences, Università degli Studi di Milano, Via Mangiagalli, 25, 20133 Milan, Italy.
- Department of Pharmacological and Biomolecular Sciences "Rodolfo Paoletti", Università degli Studi di Milano, Via Balzaretti, 9, 20133 Milan, Italy; Department of Experimental Oncology, European Institute of Oncology (I…
- Department of Pharmacological and Biomolecular Sciences "Rodolfo Paoletti", Università degli Studi di Milano, Via Balzaretti, 9, 20133 Milan, Italy. Electronic address: Danilo.Norata@unimi.it.
Förderung
- Fondazione Umberto Veronesi
- Ministero dell'Istruzione dell'Università e della Ricerca
- European Atherosclerosis Society
- University of Milan
Zitieren
APA
Da Dalt, L., Giancane, G., Fantini, F., Castiglioni, L., Uboldi, P., Pedretti, S., Mitro, N., Moregola, A., Terenghi, O., Sironi, L., Baragetti, A., & Norata, G. D. (2026). Systemic OPA1 overexpression reshapes cardiovascular metabolism and cardiac physiology during high-fat diet feeding. Vascular Pharmacology, 165, 107713. https://doi.org/10.1016/j.vph.2026.107713
Vancouver
Da Dalt L, Giancane G, Fantini F, Castiglioni L, Uboldi P, Pedretti S, et al. Systemic OPA1 overexpression reshapes cardiovascular metabolism and cardiac physiology during high-fat diet feeding. Vascular Pharmacology. 2026;165:107713. doi:10.1016/j.vph.2026.107713
BibTeX
@article{DaDalt2026,
author = {Da Dalt, Lorenzo and Giancane, Giulia and Fantini, Francesca and Castiglioni, Laura and Uboldi, Patrizia and Pedretti, Silvia and Mitro, Nico and Moregola, Annalisa and Terenghi, Ottavia and Sironi, Luigi and Baragetti, Andrea and Norata, Giuseppe Danilo},
title = {Systemic OPA1 overexpression reshapes cardiovascular metabolism and cardiac physiology during high-fat diet feeding},
journal = {Vascular Pharmacology},
year = {2026},
volume = {165},
pages = {107713},
doi = {10.1016/j.vph.2026.107713}
}
EUVIMED